Quidel Corp. appointed Edward Michael to the board.

Michael serves as the co-founder and managing partner of LionBird (Ventures) Ltd., a venture capital firm. In addition, he is a board member of NeuMoDx Molecular Inc., a molecular diagnostics company. Michael was also executive vice president of diagnostic products at Abbott Laboratories.

Quidel also expanded the board size from eight to nine directors.

San Diego-based Quidel develops, manufactures and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology.